Abstract:Proteolysis targeting chimera (PROTAC) technology, a groundbreaking strategy for degradation of pathogenic proteins by hijacking of the ubiquitin-proteasome-system has become a promising strategy in drug design. However, the real-time monitoring and visualization of protein degradation processes have been long-standing challenges in the realm of drug development. In this research, we sought to amalgamate the highly efficient protein-degrading capabilities of PROTAC technology with the visualization attributes of fluorescent probes, with the potential to pave the path for the design and development of a novel class of visual PROTACs. These novel PROTACs uniquely possess both fluorescence imaging and therapeutic characteristics, all with the goal of enabling real-time observations of protein degradation processes. Our approach involved the utilization of a high ER-targeting fluorescent probe, previously reported in our laboratory, which served as a warhead that specifically binds to the protein of interest (POI). Additionally, a VHL ligand for recruiting E3 ligase and linkers of various lengths were incorporated to synthesize a series of novel ER-inherent fluorescence PROTACs. Among them, compound A3 demonstrated remarkable efficiency in degrading ERα proteins (DC 50 = 0.12 μM) and displaying exceptional anti-proliferative activity against MCF-7 cells (IC 50 = 0.051 μM). Furthermore, it exhibited impressive fluorescence imaging performance, boasting an emission wavelength of up to 582 nm, a Stokes shift of 116 nm, and consistent optical properties. These attributes make it especially suitable for the real-time, in situ tracking of ERα protein degradation processes, thus may serve as a privileged visual theranostic PROTAC for ERα + breast cancer. This study not only broadens the application spectrum of PROTAC technology but also introduces a novel approach for real-time visualization of protein degradation processes, ultimately enhancing the diagnostic and treatment efficacy of PROTACs.

Activable Targeted Protein Degradation Platform Based on Light-triggered Singlet Oxygen

PROTACs: an Emerging Targeting Technique for Protein Degradation in Drug Discovery

Hydrogen Peroxide-Inducible PROTACs for Targeted Protein Degradation in Cancer Cells

Light-Controllable PROTACs for Temporospatial Control of Protein Degradation

Light-induced Control of Protein Destruction by Opto-Protac.

Stimuli‐Responsive PROTACs for Controlled Protein Degradation

A Photoactivatable Upconverting Nanodevice Boosts Lysosomal Escape of PROTAC Degraders for Enhanced Combination Therapy

A modular PROTAC design for target destruction using a degradation signal based on a single amino acid

Light-Induced Protein Degradation With Photocaged Protacs

Engineering POLYTAC Nanoparticles for Bioorthogonal Click Reaction-Enforced Protein Degradation and Breast Cancer Therapy

Small Molecule PROTACs in Targeted Therapy: an Emerging Strategy to Induce Protein Degradation.

Precise Modulation of Protein Degradation by Smart PROTACs

Stimuli-activatable PROTACs for precise protein degradation and cancer therapy

Progress of small molecules for targeted protein degradation: PROTACs and other technologies

Near-Infrared-Activatable PROTAC Nanocages for Controllable Target Protein Degradation and On-Demand Antitumor Therapy.

Photo-regulated PROTACs: A novel tool for temporal control of targeted protein degradation

PROTACs: Emerging Targeted Protein Degradation Approaches for Advanced Druggable Strategies

Fluorescence theranostic PROTACs for real-time visualization of ERα degradation

PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy

Peptide-Mediated Small Molecule Lysosome-Targeting Chimeras for Targeted Degradation of Membrane and Intracellular Proteins

Delivering on Cell‐Selective Protein Degradation Using Chemically Tailored PROTACs